BioBoston Consulting

Understanding Commissioning, Qualification, and Validation

"What is Commissioning, Qualification, and Validation (C&Q)?"

In regulated industries, understanding the distinctions between Commissioning, Qualification, and Validation is essential for maintaining high standards of safety, quality, and compliance. By exploring the unique roles of each, companies can ensure that their processes, systems, and equipment are always ready for operation, compliant with regulations, and capable of delivering consistent results.  What is Commissioning, […]

Investigational New Drug (IND) Application Services

Investigational New Drug (IND) services for FDA submission

For many drug developers, IND preparation is where scientific progress meets regulatory reality. We often see strong preclinical programs slowed by fragmented documentation, unclear regulatory strategy, or misalignment between nonclinical, CMC, and clinical plans. These gaps can trigger FDA questions, delay trial start, and increase development risk.  A well-structured IND keeps programs moving forward.    […]

Internal & Supplier Audits in Life Sciences:

Internal audits and supplier audits for life sciences companies

Most audit programs look adequate on paper, until the same findings keep coming back. We often see life sciences organizations conducting regular internal and supplier audits, yet still facing recurring observations, supplier disruptions, or late-stage inspection surprises. The issue is rarely the frequency of audits; it is how effectively insights are identified, prioritized, and acted upon.  Well-executed audits should reduce […]

Quality Management Systems (QMS) Services

Risk Management (ICH Q9) Integration

When QMS Gaps Start Affecting Daily Operations  We often engage organizations after quality issues begin to surface operationally, not just during inspections.  Common signals include:  SOPs that exist, but are outdated, inconsistent, or not followed in practice  CAPAs that close on paper but reappear during the next audit  Change controls that stall programs or bypass risk […]

How to Perform FDA-Compliant Computer System Validation

Audit-ready CSV programs, IQ/OQ/PQ validation, and GxP system compliance for biotech and pharma companies

For Life sciences such as Pharmaceutical, Biotech, and Medical device companies, computerized systems are at the heart of operations, quality control, and regulatory compliance.  Improper Computer System Validation (CSV) can lead to audit findings, data integrity issues, 483 observations, and regulatory delays, jeopardizing both product approval and patient safety.  Performing CSV in compliance with FDA, GxP, and international standards ensures your systems are validated, fully documented, and audit ready.    A Real […]

Market Leaders Mastering FDA Inspection-Readiness

Global Excellence Award – Best Life Science Business Consultancy 2025

Life sciences organizations today face growing pressure to launch new programs, expand into global markets, and comply with increasingly stringent regulatory requirements. We often see teams needing more than strategy documents, they require practical guidance rooted in regulatory experience, operational discipline, and clinical development expertise.  BioBoston Consulting provides end-to-end Life sciences consulting services, helping companies navigate the complexities of Biotech, Pharmaceutical, and Medtech operations from concept to commercialization.  […]

Top 10 Consulting Firms Influencing the Next Phase of Life Sciences and Biotech

FDA inspection readiness consulting

Life sciences organizations are under sustained pressure to advance development programs, expand into global markets, and meet evolving regulatory expectations. We often work with companies that have a strong strategic vision but need experienced, execution-focused support to translate plans into compliant, inspection-ready operations across regulatory, clinical, and commercial functions. BioBoston Consulting provides end-to-end life sciences […]

Consulting Firms Influencing the Next Phase of Life Sciences and Biotech

FDA inspection readiness consulting

Life sciences organizations are under sustained pressure to advance development programs, expand into global markets, and meet evolving regulatory expectations. We often work with companies that have a strong strategic vision but need experienced, execution-focused support to translate plans into compliant, inspection-ready operations across regulatory, clinical, and commercial functions. BioBoston Consulting provides end-to-end life sciences […]